Lantus 100 UNT/ML Injectable Solution
- RxCUI
- 285018
- RxNorm name
- Lantus 100 UNT/ML Injectable Solution
- Display name
- Lantus 100 UNT/ML Injectable Solution
- Full name
- Lantus 100 UNT/ML Injectable Solution
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:23
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 021081 | Lantus | insulin glargine | 351(a) | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lantus Solostar | INSULIN GLARGINE | sanofi-aventis U.S. LLC | d5e07a0c-7e14-4756-9152-9fea485d654a | 2025-06-02 | Warnings, Adverse reactions | 285018 |
| Lantus | INSULIN GLARGINE | A-S Medication Solutions | ae27bb66-5dbe-4f01-a89e-f4fa7cb09c99 | 2023-02-04 | Warnings, Adverse reactions | 285018 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| d5e07a0c-7e14-4756-9152-9fea485d654a | Lantus 100 UNT/ML Injectable Solution [PSN] · insulin glargine 100 UNT/ML Injectable Solution [Lantus] [SBD] · Lantus 100 UNT/ML Injectable Solution [SY] | 3 | 35 | These highlights do not include all the information needed to use LANTUS safely and effectively. See full prescribing information for LANTUS. LANTUS ® (insulin glargine) injection, for subcutaneous use Initial U.S. Approval: 2000 | 20250602 |
| ae27bb66-5dbe-4f01-a89e-f4fa7cb09c99 | Lantus 100 UNT/ML Injectable Solution [PSN] · insulin glargine 100 UNT/ML Injectable Solution [Lantus] [SBD] · Lantus 100 UNT/ML Injectable Solution [SY] | 3 | 12 | These highlights do not include all the information needed to use LANTUS safely and effectively. See full prescribing information for LANTUS. LANTUS ® (insulin glargine) injection, for subcutaneous use Initial U.S. Approval: 2000 | 20230204 |
| 6c81d894-67eb-4c68-8af1-8cc220adb6f5 | Lantus 100 UNT/ML Injectable Solution [PSN] · insulin glargine 100 UNT/ML Injectable Solution [Lantus] [SBD] · Lantus 100 UNT/ML Injectable Solution [SY] | 3 | 2 | These highlights do not include all the information needed to use LANTUS safely and effectively. See full prescribing information for LANTUS. LANTUS (insulin glargine [rDNA origin] injection) solution for subcutaneous injection Initial U.S. Approval: 2000 | 20140109 |
| b861fdd9-e134-436e-8c0c-a60dd0006dd3 | Lantus 100 UNT/ML Injectable Solution [PSN] · insulin glargine 100 UNT/ML Injectable Solution [Lantus] [SBD] · Lantus 100 UNT/ML Injectable Solution [SY] | 3 | 2 | These highlights do not include all the information needed to use LANTUS safely and effectively. See full prescribing information for LANTUS. LANTUS (insulin glargine [rDNA origin] injection) solution for subcutaneous injection Initial U.S. Approval: 2000 | 20100105 |
| f2149727-c2df-41b0-97f1-45ea75e0aa1a | Lantus 100 UNT/ML Injectable Solution [PSN] · insulin glargine 100 UNT/ML Injectable Solution [Lantus] [SBD] · Lantus 100 UNT/ML Injectable Solution [SY] | 3 | 1 | These highlights do not include all the information needed to use LANTUS safely and effectively. See full prescribing information for LANTUS. LANTUS (insulin glargine [rDNA origin] injection) solution for subcutaneous injection Initial U.S. Approval: 2000 | 20110920 |